Tech Company M&A Transactions
Iconic Therapeutics Acquisition
Iconic Therapeutics was acquired by Entelos. The transaction was announced on 8/30/2007. Entelos said the transaction price was $14.1 million.
Transaction Overview
Company Name
Acquired By
Announced On
8/30/2007
Transaction Type
M&A
Amount
$14,100,000
M&A Terms
The initial consideration for the acquisition is to be satisfied by the issue of up to 12,776,658 Entelos shares (to be adjusted for net working capital) and a potential maximum earn out payment of $25.0 million if certain financial milestones are achieved. Such deferred consideration is to be also satisfied in Entelos shares, which will be based on a 10-day average closing price for the period prior to an earn out payment.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
701 Gateway Blvd. 100
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Greene
Chief Medical Officer
Gabriela Burian
Chief Operating Officer
Brandon Smith
VP - Operations
Cynthia Porter
Browse more venture capital transactions:
Prev: 8/29/2007: MeetingSense Software venture capital transaction
Next: 8/30/2007: Helixis venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs